Gold Nanoparticles for the Improved Anticancer Drug Delivery of the Active Component of Oxaliplatin

Abstract

About

This paper, published in 1950, received 677 indexed citations. Written by Sarah D. Brown, Paola Nativo, J.L. Smith, David Stirling, P. R. Edwards, Balaji Venugopal, David J. Flint, Jane A. Plumb, Duncan Graham and Nial Wheate covering the research area of Oncology, Electronic, Optical and Magnetic Materials and Biomaterials. It is primarily cited by scholars working on Biomaterials (318 citations), Materials Chemistry (281 citations) and Biomedical Engineering (270 citations). Published in Journal of the American Chemical Society.

In The Last Decade

doi.org/10.1021/ja908117a →

Countries where authors are citing Gold Nanoparticles for the Improved Anticancer Drug Delivery of the Active Component of Oxaliplatin

Since Specialization

Citations

This map shows the geographic impact of Gold Nanoparticles for the Improved Anticancer Drug Delivery of the Active Component of Oxaliplatin. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gold Nanoparticles for the Improved Anticancer Drug Delivery of the Active Component of Oxaliplatin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gold Nanoparticles for the Improved Anticancer Drug Delivery of the Active Component of Oxaliplatin more than expected).

Fields of papers citing Gold Nanoparticles for the Improved Anticancer Drug Delivery of the Active Component of Oxaliplatin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of Gold Nanoparticles for the Improved Anticancer Drug Delivery of the Active Component of Oxaliplatin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Gold Nanoparticles for the Improved Anticancer Drug Delivery of the Active Component of Oxaliplatin.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

This paper is also available at doi.org/10.1021/ja908117a.

Explore hit-papers with similar magnitude of impact

Breakdown of academic impact, for the paper Gut microbial communities of social bees Breakdown of academic impact, for the paper Stability analysis of swarms Breakdown of academic impact, for the paper Decisions and Nondecisions: An Analytical Framework Breakdown of academic impact, for the paper Mercury pollution : integration and synthesis Breakdown of academic impact, for the paper Identification of a Peptide Recognized by Five Melanoma-Specific Human Cytotoxic T Cell Lines Breakdown of academic impact, for the paper Signaling pathways in insulin action: molecular targets of insulin resistance Breakdown of academic impact, for the paper Risk factors for cholangiocarcinoma Breakdown of academic impact, for the paper Double-blind, Placebo-controlled Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis